JP2012512858A5 - - Google Patents

Download PDF

Info

Publication number
JP2012512858A5
JP2012512858A5 JP2011541582A JP2011541582A JP2012512858A5 JP 2012512858 A5 JP2012512858 A5 JP 2012512858A5 JP 2011541582 A JP2011541582 A JP 2011541582A JP 2011541582 A JP2011541582 A JP 2011541582A JP 2012512858 A5 JP2012512858 A5 JP 2012512858A5
Authority
JP
Japan
Prior art keywords
group
poly
molecule
glycan
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011541582A
Other languages
English (en)
Japanese (ja)
Other versions
JP5877712B2 (ja
JP2012512858A (ja
Filing date
Publication date
Priority claimed from GBGB0823309.0A external-priority patent/GB0823309D0/en
Application filed filed Critical
Publication of JP2012512858A publication Critical patent/JP2012512858A/ja
Publication of JP2012512858A5 publication Critical patent/JP2012512858A5/ja
Application granted granted Critical
Publication of JP5877712B2 publication Critical patent/JP5877712B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011541582A 2008-12-19 2009-12-21 官能基化試薬およびその使用 Active JP5877712B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13901408P 2008-12-19 2008-12-19
GBGB0823309.0A GB0823309D0 (en) 2008-12-19 2008-12-19 Functionalising reagents and their uses
GB0823309.0 2008-12-19
US61/139,014 2008-12-19
PCT/GB2009/002924 WO2010070300A2 (en) 2008-12-19 2009-12-21 Functionalising reagents and their uses

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015137984A Division JP6240122B2 (ja) 2008-12-19 2015-07-09 官能基化試薬およびその使用

Publications (3)

Publication Number Publication Date
JP2012512858A JP2012512858A (ja) 2012-06-07
JP2012512858A5 true JP2012512858A5 (enExample) 2013-02-07
JP5877712B2 JP5877712B2 (ja) 2016-03-08

Family

ID=40343997

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011541582A Active JP5877712B2 (ja) 2008-12-19 2009-12-21 官能基化試薬およびその使用
JP2015137984A Active JP6240122B2 (ja) 2008-12-19 2015-07-09 官能基化試薬およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015137984A Active JP6240122B2 (ja) 2008-12-19 2015-07-09 官能基化試薬およびその使用

Country Status (8)

Country Link
US (2) US8785595B2 (enExample)
EP (2) EP2886132B1 (enExample)
JP (2) JP5877712B2 (enExample)
CN (2) CN104558098B (enExample)
ES (2) ES2674099T3 (enExample)
GB (1) GB0823309D0 (enExample)
PL (2) PL2373675T3 (enExample)
WO (1) WO2010070300A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0823309D0 (en) 2008-12-19 2009-01-28 Univ Bath Functionalising reagents and their uses
GB201007356D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIIa
CN107417745A (zh) 2011-08-08 2017-12-01 加州理工学院 线虫小分子的应用
US9445596B2 (en) 2011-08-08 2016-09-20 California Institute Of Technology Small molecule compounds for the control of nematodes
EP2907823A1 (en) * 2014-02-14 2015-08-19 Gene Signal International SA Polypeptide fragments of 168A-T2 and compositions comprising them for use in treating cancer
GB201419108D0 (en) * 2014-10-27 2014-12-10 Glythera Ltd Materials and methods relating to linkers for use in antibody drug conjugates
WO2018039591A1 (en) 2016-08-25 2018-03-01 California Institute Of Technology Ascaroside treatment of autoimmune and inflammatory diseases
EP3829647A1 (en) 2018-07-31 2021-06-09 Astrazeneca AB Linkers and conjugates
WO2020236621A1 (en) 2019-05-17 2020-11-26 California Institute Of Technology Ascaroside derivatives and methods of use
CN115998707A (zh) * 2021-10-21 2023-04-25 福州大学 一种聚二硫多肽纳米粒及其制备方法和多肽药物口服制剂
CN115181091A (zh) * 2022-06-21 2022-10-14 江苏联环药业股份有限公司 一种贝他斯汀的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
CA1236454A (en) * 1984-06-27 1988-05-10 John J. Tsai Monomeric cationic glycoside derivatives
US4719272A (en) * 1984-06-27 1988-01-12 National Starch And Chemical Corporation Monomeric cationic glycoside derivatives
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
EP0298101A1 (en) * 1987-01-15 1989-01-11 Celltech Limited Thiol-reactive cross-linking reagents
DE3942355A1 (de) * 1989-12-21 1991-06-27 Boehringer Mannheim Gmbh N- und o-substituierte aminophenolderivate, zwischenprodukte zu deren herstellung, deren verwendung als hydrolasesubstrate, ein entsprechendes bestimmungsverfahren und hierfuer geeignetes diagnostisches mittel
DE69233069T2 (de) * 1991-03-15 2003-11-27 Amgen Inc., Thousand Oaks Pegylation von polypeptiden
DK0672142T3 (da) 1992-12-04 2001-06-18 Medical Res Council Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse
US5446090A (en) * 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
US6309646B1 (en) * 1996-05-09 2001-10-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates
WO2001062827A2 (en) * 2000-02-22 2001-08-30 Shearwater Corporation N-maleimidyl polymer derivatives
US20040214228A9 (en) 2001-09-14 2004-10-28 Ganesh Venkataraman Methods of evaluating glycomolecules for enhanced activities
CA2459040A1 (en) 2001-09-14 2003-03-27 Mimeon, Inc. Methods of making glycolmolecules with enhanced activities and uses thereof
DK1476181T3 (en) 2002-01-18 2016-05-23 Biogen Ma Inc POLYALKYLENE POLYMER COMPOUNDS AND USE THEREOF
MXPA05002620A (es) * 2002-09-09 2005-05-05 Nektar Therapeutics Al Corp Alcanales polimericos solubles en agua.
JP2004262781A (ja) * 2003-02-28 2004-09-24 Noguchi Inst 蛍光糖鎖プローブ
US20050074895A1 (en) 2003-09-05 2005-04-07 Bio-Rad Laboratories, Inc. Alkyl-substituted vinyl pyridines for mass-coded tagging of proteins
CN101223137A (zh) * 2005-07-11 2008-07-16 默克公司 制备氢化异二氢吲哚速激肽受体拮抗剂的方法
GB0823309D0 (en) 2008-12-19 2009-01-28 Univ Bath Functionalising reagents and their uses
US9209965B2 (en) 2014-01-14 2015-12-08 Microsemi Semiconductor Ulc Network interface with clock recovery module on line card

Similar Documents

Publication Publication Date Title
JP2012512858A5 (enExample)
AU2023200440B2 (en) Antagonistic anti-tumor necrosis factor receptor superfamily antibodies
Gaertner et al. Site-specific attachment of functionalized poly (ethylene glycol) to the amino terminus of proteins
CN102317305B (zh) 硫醇基官能化试剂及其用途
US20210122785A1 (en) Peptide ligands for binding to il-17
EP1955712A1 (en) Multimeric conjugate
CN111902429A (zh) 多聚体双环肽配体
ATE486090T1 (de) Erfindung betreffend glp-1 und exendin
RU2008135433A (ru) Гибриды рекомбинантных антител-белков стресса
JP2005506277A5 (enExample)
CN104736567A (zh) 阿立哌唑半抗原的抗体及其用途
CN103476798A (zh) 在粘合物质和可铁宁的粘合体上结合有抗-可铁宁抗体的复合体及其用途
JP2023510972A (ja) 抗ｓｔ２抗体及びその適用
CN107174838B (zh) 一种含锆金属有机骨架材料修饰的开管毛细管柱及其应用
RU2017103462A (ru) Материалы и способы, связанные с линкерами для применения в конъюгатах лекарственного средства и белка
JP2020500186A5 (enExample)
JP2020532565A5 (enExample)
CN109661407A (zh) 融合蛋白构建体
RU2012142654A (ru) Производные комплекса металл-сален и способ их получения
CN103601662B (zh) 一种褪黑素半抗原、褪黑素完全抗原及其制备方法和应用
CN116891454B (zh) 小分子抑制剂及制备方法与其在制备抗癌药物中的应用
CN100340543C (zh) 氰戊菊酯半抗原化合物、合成方法及其用途
FJ et al. Pneumonia from Nocardia nova in lung cancer
WO2025248090A1 (en) Novel brd4 binders
Picha et al. Engineering peptide therapeutics using MIMETIBODY™ technology